Celltrion Inc.

Byung Pil Lim

Shin Jae Chang

Kye Sook Yi

Seung Suh Hong

Soo Young Lee

Pan Kyeom Kim

Jung Sun Ahn

Man Ki Song

Sun Ju Keum

Joon Sun Yoon

Hwa Jin Lee

Cheol Min Kim

Jung Ah Choi

Sang Tae Park

Eun Bee Park

This invention relates to an adjuvant composition containing at least one binding molecule for neutralizing influenza virus and a vaccine composition containing the same. The composition containing at least one binding molecule for neutralizing influenza virus is capable of increasing the effects of a vaccine, and can thus be used as an adjuvant, which increases an immune response upon vaccine administration, and is very useful in the prevention of diseases caused by viruses.

Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same

The present invention relates to an epitope specific to hepatitis B virus surface antigen and a binding molecule binding to the same for neutralizing hepatitis B virus. Since the epitope provided by the present invention is produced by forming a three-dimensional structure and does not comprise a determinant, by which escape mutation is induced against an administration of existing vaccines or HBIg, a composition comprising an antibody biding to the epitope or a vaccine composition comprising the epitope has a very low possibility of causing a decrease in efficacy due to escape mutation. Therefore, such an antibody or vaccine composition can be very effectively used in prevention and/or treatment of HBV.

Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virus

Growing community of inventors

Seoul, South Korea

Byung Pil Lim